Former Florida congressman Dave Weldon is President-elect Donald Trump’s pick to lead the CDC, giving Robert F. Kennedy Jr. a ...

Sanofi is proposing a new model for distributing drug discounts under the federal 340B program, according to the Wall Street ...

Eli Lilly and Novo Nordisk have filed dozens of lawsuits against compounding pharmacies marketing their own versions of ...

The Senate Judiciary Committee narrowly advanced a bill Thursday that would change the way the Patent Trial and Appeal Board ...

Halozyme Therapeutics said Friday that it has pulled its proposal to buy Evotec, a struggling German biotech that Halozyme said was ...

Lexicon Pharmaceuticals is reverting to a clinical development company after facing repeated setbacks at the FDA for its type 1 diabetes and chronic kidney disease drug.

Eli Lilly has appointed Procter & Gamble CEO Jon Moeller to the board of directors, while Goldman Sachs operating partner Karen Walker will resign from ...

Biotech start­up Enve­da has raised a $130 mil­lion Se­ries C, the Col­orado com­pa­ny said Thurs­day morn­ing.

A fe­male Rett syn­drome pa­tient died Wednes­day af­ter re­ceiv­ing Neu­ro­gene’s gene ther­a­py in a clin­i­cal tri­al, the com­pa­ny dis­closed in a new ...

No­var­tis’ re­or­ga­ni­za­tion is pay­ing off, CEO Vas Narasimhan told in­vestors at an event Thurs­day in Lon­don.

Members of an FDA advisory committee were not asked to vote on AstraZeneca’s anticoagulant reversal drug Andexxa on Thursday, but they did raise several safety and efficacy concerns.